Skip to main content
Normal View

Medicinal Products Availability

Dáil Éireann Debate, Thursday - 13 February 2014

Thursday, 13 February 2014

Questions (55, 63)

Michael Moynihan

Question:

55. Deputy Michael Moynihan asked the Minister for Health the number of hospitals in which access to the asthma medication omalizumab (Xolair) is provided to patients; and if he will make a statement on the matter. [6947/14]

View answer

Michael Moynihan

Question:

63. Deputy Michael Moynihan asked the Minister for Health the reason progress has not been made in providing access to the life-changing medication for severe asthma, omalizumab (Xolair), to patients in Cork University Hospital; and if he will make a statement on the matter. [6946/14]

View answer

Written answers

I propose to take Questions Nos. 55 and 63 together.

In relation to the specific queries raised by the Deputy, as these are service matters they have been referred to the HSE for direct reply.

Question No. 56 answered with Question No. 35.
Top
Share